abs01021 Recombinant Mouse IFN-γ
參考價(jià) | ¥ 720 |
訂貨量 | ≥1 |
具體成交價(jià)以合同協(xié)議為準(zhǔn)
- 公司名稱 愛必信(上海)生物科技有限公司
- 品牌 absin
- 型號(hào) abs01021
- 產(chǎn)地
- 廠商性質(zhì) 生產(chǎn)廠家
- 更新時(shí)間 2025/6/12 19:53:32
- 訪問次數(shù) 1412
產(chǎn)品標(biāo)簽
聯(lián)系方式:愛必信18438616290 查看聯(lián)系方式
聯(lián)系我們時(shí)請(qǐng)說明是化工儀器網(wǎng)上看到的信息,謝謝!
供貨周期 | 一周 | 規(guī)格 | 20ug |
---|
概述 | |
---|---|
種屬 | Murine |
形態(tài) | Lyophilized from a 0.2 µm filtered solution in PBS, pH 7.4, containing 5 % trehalose. |
來源 | Escherichia coli. |
氨基酸序列 | HGTVIESLES LNNYFNSSGI DVEEKSLFLD IWRNWQKDGD MKILQSQIIS FYLRLFEVLK DNQAISNNIS VIESHLITTF FSNSKAKKDA FMSIAKFEVN NPQVQRQAFN ELIRVVHQLL PESSLRKRKR SRC |
內(nèi)毒素水平 | Less than 1 EU/µg of rMuIFN-γ as determined by LAL method. |
活性 | Fully biologically active when compared to standard. The ED50 as determined by an anti-viral assay using murine L929 cells infected with encephalomyocarditis (EMC) virus is less than 0.8 ng/ml, corresponding to a specific activity of > 1.3 × 106 IU/mg. |
Accession # | P01580 |
預(yù)期分子量 | Approximay 15.5 kDa, a single non-glycosylated polypeptide chain containing 133 amino acids. |
性能 | |
---|---|
溶解方法 | We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/ml. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions. |
保存方法 | This lyophilized preparation is stable at 2-8 °C, but should be kept at -20 °C for long term storage, preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8 °C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20 °C to -70 °C. Avoid repeated freeze/thaw cycles. |
純度 | > 96 % by SDS-PAGE and HPLC analyses. |
Gene IDs | 15978 |
參考文獻(xiàn) | |
---|---|
1. Pennino D, Bhavsar PK, Effner R, et al. 2012. J Allergy Clin Immunol, <br/>2. Hibi M, Hachimura S, Ise W, et al. 2003. Cytotechnology, 43: 49-55.<br/>3. Wang H, Ruan Z, Wang Y, et al. 2008. Mol Immunol, 45: 1548-56.<br/>4. Kopinski P, Przybylski G, Jarzemska A, et al. 2007. Pol Merkur Lekarski, 23: 15-21. |